Potential and real drug interactions in patients treated with abiraterone or enzalutamide in clinical practice

JOURNAL ARTICLE published 2 December 2021 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Juan Vicente-Valor | Vicente Escudero-Vilaplana | Roberto Collado-Borrell | Sara Pérez-Ramírez | Cristina Villanueva-Bueno | Álvaro Narrillos-Moraza | Sebastián García-Sánchez | Manel Beamud-Cortés | Ana Herranz | María Sanjurjo

New drugs for chemotherapy-induced nausea and vomiting: focus on palonosetron

JOURNAL ARTICLE published June 2005 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Giuseppe Tonini | Bruno Vincenzi | Daniele Santini

CNS pharmacokinetics of antifungal agents

JOURNAL ARTICLE published August 2007 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Shravan Kethireddy | David Andes

Alterations in drug disposition during pregnancy:

JOURNAL ARTICLE published August 2007 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Lucy S Hodge | Timothy S Tracy

Combination therapy of Western drugs and herbal medicines: recent advances in understanding interactions involving metabolism and efflux

JOURNAL ARTICLE published August 2012 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Chrisna Gouws | Dewald Steyn | Lissinda Du Plessis | Jan Steenekamp | Josias H Hamman

Pharmacokinetic modelling and Bayesian estimation-assisted decision tools to optimize vancomycin dosage in neonates: only one piece of the puzzle

JOURNAL ARTICLE published 2 September 2019 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Karel Allegaert | Robert Flint | Anne Smits

Current strategies with eptifibatide and other antiplatelet agents in percutaneous coronary intervention and acute coronary syndromes

JOURNAL ARTICLE published December 2005 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Lisa K Jennings

Valproate semisodium ER for migraine and cluster headache prophylaxis

JOURNAL ARTICLE published April 2010 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Brigitte V Lovell | Michael J Marmura

Pharmacokinetic and pharmacodynamic considerations for the current chronic constipation treatments

JOURNAL ARTICLE published April 2013 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Stefan Müller-Lissner

JOURNAL ISSUE published June 2007 in Expert Opinion on Drug Metabolism & Toxicology

Have physiologically-based pharmacokinetic models delivered?

JOURNAL ARTICLE published August 2011 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Andrea N Edginton | Ghanashyam Joshi

Pharmacokinetic and toxicity considerations for the use of anthracyclines in ovarian cancer treatment

JOURNAL ARTICLE published June 2011 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Matteo Morotti | Mario Valenzano Menada | Pier Luigi Venturini | Simone Ferrero

An update on chemotherapy and tumor gene expression profiles in breast cancer

JOURNAL ARTICLE published September 2012 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Sing-Huang Tan | Soo-Chin Lee

Factors influencing hepatic metabolism of antihypertensive drugs: impact on clinical response

JOURNAL ARTICLE published 2 January 2019 in Expert Opinion on Drug Metabolism & Toxicology

Research funded by Secretaría de Ciencia y Técnica, Universidad de Buenos Aires (UBACyT 20020150100142BA)

Authors: Christian Höcht | Facundo M. Bertera | Yanina Santander Plantamura | Luciano Parola | Julieta S. Del Mauro | Ariel H. Polizio

Potency and selectivity of vardenafil: a phosphodiesterase Type 5 inhibitor

JOURNAL ARTICLE published August 2005 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Frank Sommer

Sildenafil: efficacy, safety, tolerability and mechanism of action in treating erectile dysfunction

JOURNAL ARTICLE published August 2005 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Sharron H Francis | Jackie D Corbin

Inhibition effect of epigallocatechin-3-gallate on the pharmacokinetics of calcineurin inhibitors, tacrolimus, and cyclosporine A, in rats

JOURNAL ARTICLE published 2 January 2021 in Expert Opinion on Drug Metabolism & Toxicology

Research funded by National Natural Science Foundation of China (818743426) | Chinese Medicine Research Project of Health Commission of Hubei Province (ZY2019Z004) | National Key R&D Program of China (2017YFC0909900)

Authors: Xixi Huang | Rui Zhang | Tingyu Yang | Ye Wei | Chunxiao Yang | Jiani Zhou | Yani Liu | Shaojun Shi

The role for microRNAs in drug toxicity and in safety assessment

JOURNAL ARTICLE published 3 April 2015 in Expert Opinion on Drug Metabolism & Toxicology

Authors: April K Marrone | Frederick A Beland | Igor P Pogribny

Pharmacokinetic modeling to determine the minimum effective dose of disease-specific antibodies for preventing hepatitis A post-exposure

JOURNAL ARTICLE published 2 July 2020 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Megan K Young | Shu-Kay Ng | Graeme R Nimmo | Allan W Cripps

Rosiglitazone in Canada: experience in clinical practice

JOURNAL ARTICLE published April 2009 in Expert Opinion on Drug Metabolism & Toxicology

Authors: Beata Patasi | Deborah MacNair | Ryan J Marble | J Robin Conway